Klotho Neurosciences, Inc. (KLTO) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: August 22, 2025
Klotho Neurosciences, Inc. (KLTO) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
Klotho Neurosciences, Inc. (Stock Symbol: KLTO)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $39 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Klotho Neurosciences, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Klotho Neurosciences, Inc. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
Klotho Neurosciences, Inc. Stock Price Chart and Technical Analysis
Loading chart data...
Loading Klotho Neurosciences, Inc. interactive price chart and technical analysis...
Deep dive into Klotho Neurosciences, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if Klotho Neurosciences, Inc. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For Klotho Neurosciences, Inc.:
P/B Ratio3.71x
Market Cap$39M
Dividend Yield36.50%
EPS$-0.34
Book Value/Share$0.20
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently Klotho Neurosciences, Inc. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Klotho Neurosciences, Inc.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess Klotho Neurosciences, Inc.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For Klotho Neurosciences, Inc.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal Klotho Neurosciences, Inc.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For Klotho Neurosciences, Inc.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively Klotho Neurosciences, Inc. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For Klotho Neurosciences, Inc.:
Understanding Financial Statement Data
What these metrics mean: Key figures from Klotho Neurosciences, Inc.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For Klotho Neurosciences, Inc.:
Income Statement ($ Millions)
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Dividends Per Share$16.50
Shares Outstanding53M
Klotho Neurosciences, Inc. (KLTO) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Klotho Neurosciences, Inc. stock analysis.
Loading fundamental data...
Loading Klotho Neurosciences, Inc. comprehensive fundamental analysis and insider trading data...
Latest Klotho Neurosciences, Inc. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting Klotho Neurosciences, Inc. (KLTO) stock price and investment outlook.
Klotho Neurosciences, Inc. announced that its CEO, Dr. Joseph Sinkule, will present at Biotech Showcase 2025 in San Francisco on January 14, 2025, during J.P. Morgan Healthcare Week.
NEW YORK, June 9, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biogenetics company announced the findings of pre-clinical studies indicating the potential of ...
About Klotho Neurosciences, Inc. Klotho Neurosciences, Inc. (NASDAQ: KLTO), is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a ...
NEW YORK, June 24, 2025 /CNW/ -- Klotho Neuroscience, Inc. (NASDAQ: KLTO), a US-based biogenetics company developing cell and gene- based treatments to address neurological conditions, including ...
NEW YORK, July 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. ("Klotho" or the "Company") (NASDAQ: KLTO), a gene and cell therapy company focused on the treatment of neurodegenerative and ...
--Klotho Neurosciences, Inc., announced that it is partnering with AAVnerGene Inc., a Rockville, MD- based innovation-driven biotech renowned for its transformative technologies in AAV ...
About Klotho Neurosciences, Inc. Klotho Neurosciences, Inc. (NASDAQ: KLTO), is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a ...
Klotho Neurosciences, Inc. (NASDAQ: KLTO) (the "Company" or "Klotho") announced today that it is evaluating the acquisition of several complementary technologies aimed at supporting healthy brain ...
Klotho Neurosciences, Inc. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of Klotho Neurosciences, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - Klotho Neurosciences, Inc. Stock Forecast
How accurate are Klotho Neurosciences, Inc. stock predictions?
Our AI model demonstrates -24% historical accuracy for KLTO predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence Klotho Neurosciences, Inc. stock price forecasts?
Is Klotho Neurosciences, Inc. a good investment in 2025?
Based on our AI analysis, Klotho Neurosciences, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are Klotho Neurosciences, Inc. forecasts updated?
Klotho Neurosciences, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced Klotho Neurosciences, Inc. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Klotho Neurosciences, Inc. stock.
